Trial Profile
A Phase I, Randomized, Open-Labeled Pharmacokinetic Study of ALZT-OP1 in Normal Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary) ; Ibuprofen+sodium cromoglicate (Primary) ; Sodium cromoglicate (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors AZTherapies
- 20 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jul 2015 New trial record